Synergy CHC Corp. Increase (Decrease) in Notes Receivable, Related Parties
Synergy CHC Corp. (SNYR) reported Increase (Decrease) in Notes Receivable, Related Parties of $32.39 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties · last filed 2026-05-14
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for the quarter ending 2025-09-30 was -$20.43K, a 244.10% decline year-over-year.
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for the quarter ending 2025-06-30 was $51.99K.
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for the quarter ending 2025-03-31 was $833.00.
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for the quarter ending 2024-12-31 was -$63.67K.
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for fiscal 2024 was -$84.94K, a 265.75% decline from fiscal 2023.
- Synergy CHC Corp. increase (decrease) in notes receivable, related parties for fiscal 2023 was $51.24K.
| Period end | Increase (Decrease) in Notes Receivable, Related Parties 3 month | Increase (Decrease) in Notes Receivable, Related Parties 6 month | Increase (Decrease) in Notes Receivable, Related Parties 9 month | Increase (Decrease) in Notes Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$20.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $31.56K derived: sum of 2 quarters · filed 2025-11-13 | $32.39K 10-Q · filed 2025-11-13 | -$31.28K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $51.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $52.82K 10-Q · filed 2025-08-14 | -$10.84K derived: sum of 3 quarters · filed 2026-05-14 | $3.34K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $833.00 10-Q · filed 2026-05-14 | -$62.84K derived: sum of 2 quarters · filed 2026-05-14 | -$48.66K derived: sum of 3 quarters · filed 2026-05-14 | -$58.94K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$63.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$49.49K derived: sum of 2 quarters · filed 2026-04-01 | -$59.77K derived: sum of 3 quarters · filed 2026-04-01 | -$84.94K 10-K · filed 2026-04-01 |
| 2024-09-30 | $14.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.89K derived: sum of 2 quarters · filed 2025-11-13 | -$21.27K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$10.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$35.45K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$25.16K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $51.24K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |